Publications by the researcher in collaboration with ALEJANDRO LOPEZ SOTO (22)

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

  2. NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

    Cancer Research, Vol. 78, Núm. 14, pp. 3913-3925

2017

  1. Aprendizaje basado en casos clínicos en Hematología a través de un wiki colaborativo en UniOvi virtual (PAINN16-007)

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

  2. Aprendizaje basado en casos clínicos en Hematología a través de una wiki colaborativa en el Campus virtual de la Universidad de Oviedo

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

  3. Biallelic IRF8 Mutations Causing NK Cell Deficiency

    Trends in Molecular Medicine

  4. Control of Metastasis by NK Cells

    Cancer Cell, Vol. 32, Núm. 2, pp. 135-154

  5. IFN Signaling and ICB Resistance: Time is on Tumor's Side

    Trends in Cancer

  6. Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

    OncoImmunology, Vol. 6, Núm. 10

  7. Immunosurveillance of Malignant Cells with Complex Karyotypes

    Trends in Cell Biology

  8. Involvement of autophagy in NK cell development and function

    Autophagy

  9. NKG2D Signaling: The Immune Subversive Side of HDAC3

    Trends in Immunology

  10. Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade

    OncoImmunology

2016

  1. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

    OncoImmunology, Vol. 5, Núm. 2

  2. The Molecular Basis of the Immune Response to Stressed Cells and Tissues

    The Innate Immune Response to Non-infectious Stressors: Human and Animal Models (Elsevier Inc.), pp. 53-79

2015

  1. NKG2D signaling in cancer immunosurveillance

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1741-1750

  2. Pleiotropic anti-angiogenic and anti-oncogenic activities of the novel mithralog demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (EC-8042)

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

    BioMed Research International, Vol. 2014

  3. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology

2013

  1. Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor

    Journal of Immunology, Vol. 190, Núm. 8, pp. 4408-4419